CA2461128A1 - Pyrazole derivatives useful in the treatment of hyper-proliferative disorders - Google Patents

Pyrazole derivatives useful in the treatment of hyper-proliferative disorders Download PDF

Info

Publication number
CA2461128A1
CA2461128A1 CA002461128A CA2461128A CA2461128A1 CA 2461128 A1 CA2461128 A1 CA 2461128A1 CA 002461128 A CA002461128 A CA 002461128A CA 2461128 A CA2461128 A CA 2461128A CA 2461128 A1 CA2461128 A1 CA 2461128A1
Authority
CA
Canada
Prior art keywords
c6alkyl
substituted
phenyl
c6alkoxy
halo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002461128A
Other languages
English (en)
French (fr)
Inventor
Uday Khire
Chengzhi Zhang
Harold C. E. Kluender
Ingo Mugge
Zhenqiu Hong
Jianxing Shao
Neil Bifulco
Pamela A. Trail
Jacques Dumas
Rico C. Lavoie
Xiao-Gao Liu
Veena Agarwal
Sharad K. Verma
Lei Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharmaceuticals Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2461128A1 publication Critical patent/CA2461128A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA002461128A 2001-09-25 2002-09-20 Pyrazole derivatives useful in the treatment of hyper-proliferative disorders Abandoned CA2461128A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32457301P 2001-09-25 2001-09-25
US60/324,573 2001-09-25
PCT/US2002/029958 WO2003027074A1 (en) 2001-09-25 2002-09-20 Pyrazole derivatives useful in the treatment of hyper-proliferative disorders

Publications (1)

Publication Number Publication Date
CA2461128A1 true CA2461128A1 (en) 2003-04-03

Family

ID=23264199

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002461128A Abandoned CA2461128A1 (en) 2001-09-25 2002-09-20 Pyrazole derivatives useful in the treatment of hyper-proliferative disorders

Country Status (5)

Country Link
US (1) US20040180891A1 (OSRAM)
EP (1) EP1432689A1 (OSRAM)
JP (1) JP2005504098A (OSRAM)
CA (1) CA2461128A1 (OSRAM)
WO (1) WO2003027074A1 (OSRAM)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200840566A (en) * 2006-12-22 2008-10-16 Esteve Labor Dr Heterocyclyl-substituted-ethylamino-phenyl derivatives, their preparation and use as medicaments
CN104557711B (zh) * 2014-12-26 2017-12-15 南通大学 含fts结构的吡唑肟类化合物的制备和应用
CN116768797A (zh) * 2022-03-16 2023-09-19 成都苑东生物制药股份有限公司 一种吡唑类衍生物、其制备方法及用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2526469A1 (de) * 1975-06-13 1976-12-30 Bayer Ag 1-substituierte pyrazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4117145A (en) * 1975-06-13 1978-09-26 Bayer Aktiengesellschaft 1-substituted pyrazoles
NL8201321A (nl) * 1981-04-07 1982-11-01 Bayer Ag Werkwijze voor de behandeling van metastase en de groei van tumorcellen.
DE3312581A1 (de) * 1983-04-08 1984-10-11 Bayer Ag, 5090 Leverkusen Verwendung von pyrazolonderivaten bei der bekaempfung des wachstums von tumorzellen und der metastasenbildung, arzneimittel hierfuer und verfahren zu deren herstellung

Also Published As

Publication number Publication date
EP1432689A1 (en) 2004-06-30
US20040180891A1 (en) 2004-09-16
JP2005504098A (ja) 2005-02-10
WO2003027074A1 (en) 2003-04-03

Similar Documents

Publication Publication Date Title
JP5432890B2 (ja) 複素環誘導体及びその用途
CN101765596B (zh) 用于治疗过增生症状和与血管生成有关疾病的缺氧诱导因子(hif)抑制剂
DE69728673T2 (de) Substituierte biphenylisoxazolsulfonamide
JP4347051B2 (ja) インスリン様成長因子１受容体（ｉｇｆ−ｉ）のモジュレーターとしてのピリミジン誘導体
WO2004046118A2 (en) 2-4-(di-phenyl-amino)-pyrimidine derivatives useful for treating hyper-proliferative disorders
US6673818B2 (en) Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
WO2006085685A1 (ja) ピラゾール化合物
WO2007129745A1 (ja) ヘテロアリールアミド低級カルボン酸誘導体
CN102985405A (zh) 杂环化合物及p27Kip1分解抑制剂
HRP20040874A2 (en) Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
CN105566311A (zh) 噁唑及异噁唑钙释放激活的钙调节剂
US20020183362A1 (en) 2-Fluorobenzenesulfonyl compounds for the treatment of inflammation
EP2346831B1 (en) Heteroaryl diamide compounds useful as mmp-13 inhibitors
CN106604918B (zh) 多环hERG激活剂
CA2461128A1 (en) Pyrazole derivatives useful in the treatment of hyper-proliferative disorders
CN106146479B (zh) 一种有效抑制或杀灭多重耐药细菌的化合物及其制备方法与应用
US20040092552A1 (en) 2-Fluorobenzenesulfonyl compounds for the treatment of inflammation
HK40079881B (zh) 芳族磺酰胺衍生物
KR100576343B1 (ko) 1,2,4-트리아졸 유도체, 그 제조방법 및 약제학적 조성물
HK1145493A (en) Inhibitors of hypoxia inducible factor (hif) useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
CA2545478A1 (en) Indolyl-thieno'3,4-bipyrazin-3-one derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
WO2005087778A1 (en) Tricyclic furopyridine derivatives useful in the treatment of hyper-proliferative disorders

Legal Events

Date Code Title Description
FZDE Dead